Citadel Securities Starts Shire plc (SHPGY) at Add, Sets $97 Price Target

Article Stock Quotes (1) Comments (0)

An analyst at Citadel Securities initiated coverage on Shire plc (NASDAQ: SHPGY) with an Add rating and a $97 price target Wednesday afternoon.

The firm cites several reasons for the Add rating:

• sees continued growth for the company's "high-margin human genetic therapies franchise, driven by increased market share for VPRIV and Replagal
  due to Genzyme’s continued manufacturing issues"
  
• sees long-term growth "for the company’s attention deficit and hyperactivity disorder franchise in the U.S"
  
• sees upside from the launch of Vyvanse and Intuniv in Europe and other ex-U.S. markets
  
• a solid development pipeline

With shares of Shire closing at $88.06 Wednesday, Citadel's new price target suggests potential upside of about 10 percent.

For more ratings news on Shire plc click here and for the rating history of Shire plc click here.

---

Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW

---

*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here

---

---

You May Also Be Interested In

• Topeka Capital Starts InvenSense (INVN) at Buy
• Topeka Capital Starts Cavium Networks (CAVM) at Hold
• Maxim Group Assumes Yingli Green Energy (YGE) at Hold

Create E-mail Alert Related Categories

New Coverage

Add Your Comment

Name

Subject

Body

Share on Facebook

Verification
can't see the text?
click here to refresh the image.
what's this?